A

Avaxia Biologics

50 employees

Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Medical Device
Therapeutics

Date founded

2005

Funding rounds raised

Total raised

$12M

from 29 investors over 29 rounds

A

Avaxia Biologics raised undisclosed on December 1, 2014

Investors: Cherrystone Angel Group

A

Avaxia Biologics raised $3.1M on May 6, 2014

Investors: Maine Angels

A

Avaxia Biologics raised undisclosed on April 1, 2014

Investors: Cherrystone Angel Group

A

Avaxia Biologics raised $2.9M on December 20, 2013

Investors: Maine Angels and Beta Fund

A

Avaxia Biologics raised $12M on June 7, 2013

Investors: GRANITE STATE ANGELS INC, Launchpad Venture Group, Boston Harbor Angels Inc., Cherrystone Angel Group, Beacon Angels, Mass Medical Angels, Beta Fund, Golden Seeds and -

A

Avaxia Biologics raised $6.4M on December 19, 2012

Investors: Maine Angels, GRANITE STATE ANGELS INC, Boston Harbor Angels Inc., Launchpad Venture Group, Beta Fund, Keiretsu Forum / Capital, Golden Seeds, Cherrystone Angel Group and Mass Medical Angels

A

Avaxia Biologics raised undisclosed on June 1, 2012

Investors: Cherrystone Angel Group

A

Avaxia Biologics raised $4.1M on February 14, 2012

Investors: Launchpad Venture Group, Beacon Angels, Cherrystone Angel Group, Mass Medical Angels and Boston Harbor Angels Inc.

FAQ